Fenamiphos
|
CAS
22224-92-6
|
C13H22NO3PS
|
RTECS
TB3675000
|
Synonyms & Trade Names
Ethyl 3-methyl-4-(methylthio)phenyl-(1-methylethyl)phosphoramidate; Nemacur®; Phenamiphos
|
DOT ID & Guide
|
Exposure
Limits
|
NIOSH REL: TWA 0.1 mg/m3 [skin]
|
|
OSHA PEL†: none
|
IDLH
N.D.
See: IDLH INDEX
|
Conversion
|
Physical Description
Off-white to tan, waxy solid. [insecticide] [Note: Found commercially as a granular ingredient (5-15%) or in an emulsifiable concentrate (400 g/l).]
|
MW: 303.4
|
BP: ?
|
MLT: 121°F
|
Sol: 0.03%
|
VP: 0.00005 mmHg
|
IP: ?
|
|
Sp.Gr: 1.14
|
Fl.P: ?
|
UEL: ?
|
LEL: ?
|
|
|
|
Incompatibilities & Reactivities
None reported [Note: May hydrolyze under alkaline conditions.]
|
Measurement Methods
NIOSH 5600
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated/Daily
Remove: When wet or contaminated
Change: Daily
Provide: Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap flush immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
Not available.
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Nausea, vomiting, abdominal cramps, diarrhea, salivation; headache, dizziness, lassitude (weakness, exhaustion); rhinorrhea (discharge of thin mucus), chest tightness; blurred vision, miosis; cardiac irregularities; muscle fasciculation; dyspnea (breathing difficulty)
|
Target Organs
respiratory system, central nervous system, cardiovascular system, blood cholinesterase
|
|
See also: INTRODUCTION
See ICSC CARD: 0483 |
